Cite
MLA Citation
José A Perez-Molina et al.. “Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.” Lancet infectious diseases, vol. 15, no. 7, n.d., pp. 775–784. http://access.bl.uk/ark:/81055/vdc_100050919905.0x000029